The DOI matches its Crossref record; 424 of the 424 references it cites were found in a registry or an index.
International Union of Basic and Clinical Pharmacology. LXXXVII. Complement Peptide C5a, C4a, and C3a Receptors
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Melendez, A. J., & Ibrahim, F. B. M. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.3.1596 · Cited by 90
RetractedUCSF Chimera—A visualization system for exploratory research and analysis
Pettersen, E. F., Goddard, T. D., Huang, C. C., Couch, G. S., Greenblatt, D. M., Meng, E. C., & Ferrin, T. E. (2004) · Journal of Computational Chemistry · doi:10.1002/jcc.20084 · Cited by 45,828
Clustal W and Clustal X version 2.0
Larkin, M. A., Blackshields, G., Brown, N. P., Chenna, R., McGettigan, P. A., McWilliam, H., Valentin, F., Wallace, I. M., Wilm, A., Lopez, R., et al. (2007) · Bioinformatics · doi:10.1093/bioinformatics/btm404 · Cited by 28,358
Jalview Version 2—a multiple sequence alignment editor and analysis workbench
Waterhouse, A. M., Procter, J. B., Martin, D. M. A., Clamp, M., & Barton, G. J. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp033 · Cited by 10,235
dbSNP: the NCBI database of genetic variation
Sherry, S. T. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.1.308 · Cited by 7,502
Adipose Tissue as an Endocrine Organ
Kershaw, E. E., & Flier, J. S. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0395 · Cited by 5,522
Adipokines in inflammation and metabolic disease
Ouchi, N., Parker, J. L., Lugus, J. J., & Walsh, K. (2011) · Nature Reviews Immunology · doi:10.1038/nri2921 · Cited by 4,625
G PROTEIN–COUPLED RECEPTOR KINASES
Pitcher, J. A., Freedman, N. J., & Lefkowitz, R. J. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.653 · Cited by 1,361
Burns, J. M., Summers, B. C., Wang, Y., Melikian, A., Berahovich, R., Miao, Z., Penfold, M. E. T., Sunshine, M. J., Littman, D. R., Kuo, C. J., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20052144 · Cited by 1,263
β-Arrestin: a Protein that Regulates β-adrenergic Receptor Function
Lohse, M. J., Benovic, J. L., Codina, J., Caron, M. G., & Lefkowitz, R. J. (1990) · Science · doi:10.1126/science.2163110 · Cited by 1,220
Interleukin-1 Type II Receptor: A Decoy Target for IL-1 That Is Regulated by IL-4
Colotta, F., Re, F., Muzio, M., Bertini, R., Polentarutti, N., Sironi, M., Giri, J. G., Dower, S. K., Sims, J. E., & Mantovani, A. (1993) · Science · doi:10.1126/science.8332913 · Cited by 980
DeFea, K. A., Zalevsky, J., Thoma, M. S., Déry, O., Mullins, R. D., & Bunnett, N. W. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.148.6.1267 · Cited by 822
The role of the anaphylatoxins in health and disease
Klos, A., Tenner, A. J., Johswich, K.-O., Ager, R. R., Reis, E. S., & Köhl, J. (2009) · Molecular Immunology · doi:10.1016/j.molimm.2009.04.027 · Cited by 730
Self-citationTranscytosis and Surface Presentation of IL-8 by Venular Endothelial Cells
Middleton, J., Neil, S., Wintle, J., Clark-Lewis, I., Moore, H., Lam, C., Auer, M., Hub, E., & Rot, A. (1997) · Cell · doi:10.1016/s0092-8674(00)80422-5 · Cited by 729
Molecular Intercommunication between the Complement and Coagulation Systems
Amara, U., Flierl, M. A., Rittirsch, D., Klos, A., Chen, H., Acker, B., Brückner, U. B., Nilsson, B., Gebhard, F., Lambris, J. D., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903678 · Cited by 720
Self-citationPurification and Characterization of TAFI, a Thrombin-activable Fibrinolysis Inhibitor
Bajzar, L., Manuel, R., & Nesheim, M. E. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.24.14477 · Cited by 680
The chemotactic receptor for human C5a anaphylatoxin
Gerard, N. P., & Gerard, C. (1991) · Nature · doi:10.1038/349614a0 · Cited by 655
CXCR7 heterodimerizes with CXCR4 and regulates CXCL12-mediated G protein signaling
Levoye, A., Balabanian, K., Baleux, F., Bachelerie, F., & Lagane, B. (2009) · Blood · doi:10.1182/blood-2008-12-196618 · Cited by 613
Kristiansen, K. (2004) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2004.05.002 · Cited by 609
Strainic, M. G., Liu, J., Huang, D., An, F., Lalli, P. N., Muqim, N., Shapiro, V. S., Dubyak, G. R., Heeger, P. S., & Medof, M. E. (2008) · Immunity · doi:10.1016/j.immuni.2008.02.001 · Cited by 580
Fernández, H. N., Henson, P. M., Otani, A., & Hugli, T. E. (1978) · PubMed · Cited by 567
Anaphylatoxin inactivator of human plasma: its isolation and characterization as a carboxypeptidase
Bokisch, V. A., & Müller-Eberhard, H. J. (1970) · Journal of Clinical Investigation · doi:10.1172/jci106462 · Cited by 517
Faraj, M., Havel, P. J., Phélis, S., Blank, D., Sniderman, A. D., & Cianflone, K. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021309 · Cited by 501
Hugli, T. E., & Müller-Eberhard, H. J. (1978) · Advances in Immunology · doi:10.1016/s0065-2776(08)60228-x · Cited by 499
Interactions between coagulation and complement—their role in inflammation
Oikonomopoulou, K., Ricklin, D., Ward, P. A., & Lambris, J. D. (2012) · Seminars in Immunopathology · doi:10.1007/s00281-011-0280-x · Cited by 486
Complement-targeted therapeutics
Ricklin, D., & Lambris, J. D. (2007) · Nature Biotechnology · doi:10.1038/nbt1342 · Cited by 481
Savarese, T. M., & Fraser, C. M. (1992) · Biochemical Journal · doi:10.1042/bj2830001 · Cited by 473
Interaction Between the Coagulation and Complement System
Amara, U., Rittirsch, D., Flierl, M., Bruckner, U., Klos, A., Gebhard, F., Lambris, J. D., & Huber-Lang, M. (2008) · Advances in Experimental Medicine and Biology · doi:10.1007/978-0-387-78952-1_6 · Cited by 471
Self-citationChemotaxis Inhibitory Protein of Staphylococcus aureus, a Bacterial Antiinflammatory Agent
de Haas, C. J. C., Veldkamp, K. E., Peschel, A., Weerkamp, F., Van Wamel, W. J. B., Heezius, E. C. J. M., Poppelier, M. J. J. G., Van Kessel, K. P. M., & van Strijp, J. A. G. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031636 · Cited by 471
Cochrane, C. G., & Müller-Eberhard, H. J. (1968) · The Journal of Experimental Medicine · doi:10.1084/jem.127.2.371 · Cited by 461
Chemotactic Response to Human C3a and C5a Anaphylatoxins
Fernandez, H. N., Henson, P. M., Otani, A., & Hugli, T. E. (1978) · The Journal of Immunology · doi:10.4049/jimmunol.120.1.109 · Cited by 443
Adipsin: A Circulating Serine Protease Homolog Secreted by Adipose Tissue and Sciatic Nerve
Cook, K. S., Min, H. Y., Johnson, D., Chaplinsky, R. J., Flier, J. S., Hunt, C. R., & Spiegelman, B. M. (1987) · Science · doi:10.1126/science.3299705 · Cited by 427
Human adipsin is identical to complement factor D and is expressed at high levels in adipose tissue.
White, R. T., Damm, D., Hancock, N., Rosen, B. S., Lowell, B. B., Usher, P., Flier, J. S., & Spiegelman, B. M. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)50409-4 · Cited by 408
Function, structure and therapeutic potential of complement C5a receptors
Monk, P. N., Scola, A., Madala, P., & Fairlie, D. P. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707332 · Cited by 404
Self-citationThe Highly Conserved DRY Motif of Class A G Protein-Coupled Receptors: Beyond the Ground State
Rovati, G. E., Capra, V., & Neubig, R. R. (2007) · Molecular Pharmacology · doi:10.1124/mol.106.029470 · Cited by 392
Functional roles for C5a receptors in sepsis
Rittirsch, D., Flierl, M. A., Nadeau, B. A., Day, D. E., Huber-Lang, M., Mackay, C. R., Zetoune, F. S., Gerard, N. P., Cianflone, K., Köhl, J., et al. (2008) · Nature Medicine · doi:10.1038/nm1753 · Cited by 386
Scheer, A., Fanelli, F., Costa, T., De Benedetti, P. G., & Cotecchia, S. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00726.x · Cited by 386
Critical review of acylation-stimulating protein physiology in humans and rodents
Cianflone, K., Xia, Z., & Chen, L. Y. (2003) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(02)00686-7 · Cited by 364
Cutting Edge: Mast Cells Express IL-17A in Rheumatoid Arthritis Synovium
Hueber, A. J., Asquith, D. L., Miller, A. M., Reilly, J., Kerr, S., Leipe, J., Melendez, A. J., & McInnes, I. B. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903566 · Cited by 358
CXCR7/CXCR4 Heterodimer Constitutively Recruits β-Arrestin to Enhance Cell Migration
Décaillot, F. M., Kazmi, M. A., Lin, Y., Ray-Saha, S., Sakmar, T. P., & Sachdev, P. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.277038 · Cited by 333
C3a and C5a Stimulate Chemotaxis of Human Mast Cells
Hartmann, K., Henz, B. M., Krüger-Krasagakes, S., Köhl, J., Burger, R., Guhl, S., Haase, I., Lippert, U., & Zuberbier, T. (1997) · Blood · doi:10.1182/blood.v89.8.2863 · Cited by 331
Lajoie, S., Lewkowich, I. P., Suzuki, Y., Clark, J. R., Sproles, A. A., Dienger, K., Budelsky, A. L., & Wills-Karp, M. (2010) · Nature Immunology · doi:10.1038/ni.1926 · Cited by 329
Membrane attack by complement: the assembly and biology of terminal complement complexes
Tegla, C. A., Cudrici, C., Patel, S., Trippe, R., Rus, V., Niculescu, F., & Rus, H. (2011) · Immunologic Research · doi:10.1007/s12026-011-8239-5 · Cited by 321
Complement Fragment C3a Controls Mutual Cell Attraction during Collective Cell Migration
Carmona-Fontaine, C., Theveneau, E., Tzekou, A., Tada, M., Woods, M., Page, K. M., Parsons, M., Lambris, J. D., & Mayor, R. (2011) · Developmental Cell · doi:10.1016/j.devcel.2011.10.012 · Cited by 317
Birney, E. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkj133 · Cited by 310
Adipsin and an endogenous pathway of complement from adipose cells.
Choy, L. N., Rosen, B. S., & Spiegelman, B. M. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42338-1 · Cited by 295
Inhibiting the C5–C5a receptor axis
Woodruff, T. M., Nandakumar, K. S., & Tedesco, F. (2011) · Molecular Immunology · doi:10.1016/j.molimm.2011.04.014 · Cited by 289
Lalli, P. N., Strainic, M. G., Yang, M., Lin, F., Medof, M. E., & Heeger, P. S. (2008) · Blood · doi:10.1182/blood-2008-04-151068 · Cited by 271
Fonseca, M. I., Ager, R. R., Chu, S.-H., Yazan, O., Sanderson, S. D., LaFerla, F. M., Taylor, S. M., Woodruff, T. M., & Tenner, A. J. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901005 · Cited by 268
Complement in health and disease
Carroll, M. V., & Sim, R. B. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.06.005 · Cited by 266
Molecular Cloning and Characterization of the Human Anaphylatoxin C3a Receptor
Ames, R. S., Li, Y., Sarau, H. M., Nuthulaganti, P., Foley, J. J., Ellis, C., Zeng, Z., Su, K., Jurewicz, A. J., Hertzberg, R. P., et al. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.34.20231 · Cited by 264
Chronic Inflammation Links Cardiovascular, Metabolic and Renal Diseases
Manabe, I. (2011) · Circulation Journal · doi:10.1253/circj.cj-11-1184 · Cited by 263
C5L2, a Nonsignaling C5A Binding Protein
Okinaga, S., Slattery, D., Humbles, A., Zsengeller, Z., Morteau, O., Kinrade, M. B., Brodbeck, R. M., Krause, J. E., Choe, H.-R., Gerard, N. P., et al. (2003) · Biochemistry · doi:10.1021/bi034489v · Cited by 261
Wingrove, J. A., DiScipio, R. G., Chen, Z., Potempa, J., Travis, J., & Hugli, T. E. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)37046-2 · Cited by 255
Cancer and the Complement Cascade
Rutkowski, M. J., Sughrue, M. E., Kane, A. J., Mills, S. A., & Parsa, A. T. (2010) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-10-0225 · Cited by 250
Fernandez, H. N., & Hugli, T. E. (1978) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)38013-4 · Cited by 249
The C5a Receptor (C5aR) C5L2 Is a Modulator of C5aR-mediated Signal Transduction
Bamberg, C. E., Mackay, C. R., Lee, H., Zahra, D., Jackson, J., Lim, Y. S., Whitfeld, P. L., Craig, S., Corsini, E., Lu, B., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.092106 · Cited by 249
Nilsson, G., Johnell, M., Hammer, C. H., Tiffany, H. L., Nilsson, K., Metcalfe, D. D., Siegbahn, A., & Murphy, P. M. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.4.1693 · Cited by 248
Activation of the complement system generates antibacterial peptides
Nordahl, E. A., Rydengård, V., Nyberg, P., Nitsche, D. P., Mörgelin, M., Malmsten, M., Björck, L., & Schmidtchen, A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0406678101 · Cited by 247
Cain, S. A., & Monk, P. N. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c100714200 · Cited by 245
Self-citationFindlay, J. B. C., & Pappin, D. J. C. (1986) · Biochemical Journal · doi:10.1042/bj2380625 · Cited by 243
C5L2 is critical for the biological activities of the anaphylatoxins C5a and C3a
Chen, N.-J., Mirtsos, C., Suh, D., Lu, Y.-C., Lin, W.-J., McKerlie, C., Lee, T., Baribault, H., Tian, H., & Yeh, W.-C. (2007) · Nature · doi:10.1038/nature05559 · Cited by 243
Functional Microdomains in G-protein-coupled Receptors
Ballesteros, J., Kitanovic, S., Guarnieri, F., Davies, P., Fromme, B. J., Konvicka, K., Chi, L., Millar, R. P., Davidson, J. S., Weinstein, H., et al. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.17.10445 · Cited by 241
Postma, B., Poppelier, M. J., van Galen, J. C., Prossnitz, E. R., van Strijp, J. A. G., de Haas, C. J. C., & van Kessel, K. P. M. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.11.6994 · Cited by 235
Cathepsin B: a potential prognostic marker for inflammatory breast cancer
Nouh, M. A., Mohamed, M. M., El-Shinawi, M., Shaalan, M. A., Cavallo-Medved, D., Khaled, H. M., & Sloane, B. F. (2011) · Journal of Translational Medicine · doi:10.1186/1479-5876-9-1 · Cited by 234
Complement C3a and C5a Induce Different Signal Transduction Cascades in Endothelial Cells
Schraufstatter, I. U., Trieu, K., Sikora, L., Sriramarao, P., & DiScipio, R. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.4.2102 · Cited by 233
Microbial Hijacking of Complement–Toll-Like Receptor Crosstalk
Wang, M., Krauss, J. L., Domon, H., Hosur, K. B., Liang, S., Magotti, P., Triantafilou, M., Triantafilou, K., Lambris, J. D., & Hajishengallis, G. (2010) · Science Signaling · doi:10.1126/scisignal.2000697 · Cited by 228
Complement Component C3 Mediates Inflammatory Injury Following Focal Cerebral Ischemia
Mocco, J., Mack, W. J., Ducruet, A. F., Sosunov, S. A., Sughrue, M. E., Hassid, B. G., Nair, M. N., Laufer, I., Komotar, R. J., Claire, M., et al. (2006) · Circulation Research · doi:10.1161/01.res.0000232544.90675.42 · Cited by 226
Inactivation of C3a and C5a Octapeptides by Carboxypeptidase R and Carboxypeptidase N
Campbell, W. D., Lazoura, E., Okada, N., & Okada, H. (2002) · Microbiology and Immunology · doi:10.1111/j.1348-0421.2002.tb02669.x · Cited by 224
Over One Hundred Peptide-Activated G Protein-Coupled Receptors Recognize Ligands with Turn Structure
Tyndall, J. D. A., Pfeiffer, B., Abbenante, G., & Fairlie, D. P. (2005) · Chemical Reviews · doi:10.1021/cr040689g · Cited by 222
Walton, T. A., & Sousa, M. C. (2004) · Molecular Cell · doi:10.1016/j.molcel.2004.07.023 · Cited by 221
Baldo, A., Sniderman, A. D., St-Luce, S., Avramoglu, R. K., Maslowska, M., Hoang, B., Monge, J. C., Bell, A., Mulay, S., & Cianflone, K. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116733 · Cited by 221
A chemogenomic analysis of the transmembrane binding cavity of human G‐protein‐coupled receptors
Surgand, J., Rodrigo, J., Kellenberger, E., & Rognan, D. (2006) · Proteins: Structure, Function, and Bioinformatics · doi:10.1002/prot.20768 · Cited by 220
Reca, R., Mastellos, D., Majka, M., Marquez, L., Ratajczak, J., Franchini, S., Glodek, A., Honczarenko, M., Spruce, L. A., Janowska-Wieczorek, A., et al. (2003) · Blood · doi:10.1182/blood-2002-10-3233 · Cited by 220
Joost, P., & Methner, A. (2002) · Genome Biology · doi:10.1186/gb-2002-3-11-research0063 · Cited by 219
Hack, C. E., Nuijens, J. H., Felt-Bersma, R. J. F., Schreuder, W. O., Eerenberg-Belmer, A. J. M., Paardekooper, J., Bronsveld, W., & Thijs, L. G. (1989) · The American Journal of Medicine · doi:10.1016/0002-9343(89)90224-6 · Cited by 216
Gosling, J., Dairaghi, D. J., Wang, Y., Hanley, M., Talbot, D., Miao, Z., & Schall, T. J. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.6.2851 · Cited by 208
A new biologic role for C3a and C3a desArg: regulation of TNF-α and IL-1 β synthesis
Takabayashi, T., Vannier, E., Clark, B. D., Margolis, N. H., Dinarello, C. A., Burke, J. F., & Gelfand, J. A. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.9.3455 · Cited by 207
An Anti-inflammatory Function for the Complement Anaphylatoxin C5a-binding Protein, C5L2
Gerard, N. P., Lu, B., Liu, P., Craig, S., Fujiwara, Y., Okinaga, S., & Gerard, C. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.c500287200 · Cited by 201
Ames, R. S., Lee, D., Foley, J. J., Jurewicz, A. J., Tornetta, M. A., Bautsch, W., Settmacher, B., Klos, A., Erhard, K. F., Cousins, R. D., et al. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.10.6341 · Cited by 196
Self-citationNormal pregnancy is characterized by systemic activation of the complement system
Richani, K., Soto, E., Romero, R., Espinoza, J., Chaiworapongsa, T., Nien, J. K., Edwin, S., Kim, Y. M., Hong, J.-S., & Mazor, M. (2005) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767050500072722 · Cited by 196
Complement drives Th17 cell differentiation and triggers autoimmune arthritis
Hashimoto, M., Hirota, K., Yoshitomi, H., Maeda, S., Teradaira, S., Akizuki, S., Prieto-Martin, P., Nomura, T., Sakaguchi, N., Köhl, J., et al. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20092301 · Cited by 195
Specific interactions of chemoattractant factor receptors with G-proteins
Amatruda, T. T., Gerard, N. P., Gerard, C., & Simon, M. I. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)82183-4 · Cited by 194
Ohno, M., Hirata, T., Enomoto, M., Araki, T., Ishimaru, H., & Takahashi, T. A. (2000) · Molecular Immunology · doi:10.1016/s0161-5890(00)00067-5 · Cited by 194
Alewijnse, A. E., Timmerman, H., Jacobs, E. H., Smit, M. J., Roovers, E., Cotecchia, S., & Leurs, R. (2000) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)26497-x · Cited by 191
Schraufstatter, I. U., DiScipio, R. G., Zhao, M., & Khaldoyanidi, S. K. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803055 · Cited by 189
Weber, M., Blair, E., Simpson, C. V., O'Hara, M., Blackburn, P. E., Rot, A., Graham, G. J., & Nibbs, R. J. B. (2004) · Molecular Biology of the Cell · doi:10.1091/mbc.e03-09-0634 · Cited by 188
Mamane, Y., Chung Chan, C., Lavallee, G., Morin, N., Xu, L.-J., Huang, J., Gordon, R., Thomas, W., Lamb, J., Schadt, E. E., et al. (2009) · Diabetes · doi:10.2337/db09-0323 · Cited by 188
Antimicrobial activities of heparin‐binding peptides
Andersson, E., Rydengård, V., Sonesson, A., Mörgelin, M., Björck, L., & Schmidtchen, A. (2004) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.2004.04035.x · Cited by 187
Mechanism of action of the group A streptococcal C5a inactivator.
Wexler, D. E., Chenoweth, D. E., & Cleary, P. P. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.23.8144 · Cited by 186
C5L2 Is a Functional Receptor for Acylation-stimulating Protein
Kalant, D., MacLaren, R., Cui, W., Samanta, R., Monk, P. N., Laporte, S. A., & Cianflone, K. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m406921200 · Cited by 177
Self-citationStreptococcal C5a peptidase is a highly specific endopeptidase
Cleary, P. P., Prahbu, U., Dale, J. B., Wexler, D. E., & Handley, J. (1992) · Infection and Immunity · doi:10.1128/iai.60.12.5219-5223.1992 · Cited by 176
Ignatius, A., Schoengraf, P., Kreja, L., Liedert, A., Recknagel, S., Kandert, S., Brenner, R. E., Schneider, M., Lambris, J. D., & Huber‐Lang, M. (2011) · Journal of Cellular Biochemistry · doi:10.1002/jcb.23186 · Cited by 176
The Chemoattractant Receptor-like Protein C5L2 Binds the C3a des-Arg77/Acylation-stimulating Protein
Kalant, D., Cain, S. A., Maslowska, M., Sniderman, A. D., Cianflone, K., & Monk, P. N. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m206169200 · Cited by 175
Self-citationExpression cloning of the human C3a anaphylatoxin receptor (C3aR) from differentiated U‐937 cells
Crass, T., Raffetseder, U., Martin, U., Grove, M., Klos, A., Köhl, J., & Bautsch, W. (1996) · European Journal of Immunology · doi:10.1002/eji.1830260840 · Cited by 174
Self-citationLiang, S., Krauss, J. L., Domon, H., McIntosh, M. L., Hosur, K. B., Qu, H., Li, F., Tzekou, A., Lambris, J. D., & Hajishengallis, G. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003252 · Cited by 173
Shinjyo, N., Ståhlberg, A., Dragunow, M., Pekny, M., & Pekna, M. (2009) · Stem Cells · doi:10.1002/stem.225 · Cited by 171
The Human C3a Receptor Is Expressed on Neutrophils and Monocytes, but Not on B or T Lymphocytes
Martin, U., Bock, D., Arseniev, L., Tornetta, M. A., Ames, R. S., Bautsch, W., Köhl, J., Ganser, A., & Klos, A. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.2.199 · Cited by 171
Self-citationReceptor for the C3a anaphylatoxin is expressed by neurons and glial cells
Davoust, N., Jones, J. L., Stahel, P. F., Ames, R. S., & Barnum, S. R. (1999) · Glia · Cited by 167
Elsner, J., Oppermann, M., Czech, W., Dobos, G., Schöpf, E., Norgauer, J., & Kapp, A. (1994) · European Journal of Immunology · doi:10.1002/eji.1830240304 · Cited by 167
Moll, G., Jitschin, R., von Bahr, L., Rasmusson, I., Sundberg, B., Lönnies, L., Elgue, G., Nilsson‐Ekdahl, K., Mougiakakos, D., Lambris, J. D., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021703 · Cited by 166
Liu, B., Wei, L., Meyerle, C., Tuo, J., Sen, H. N., Li, Z., Chakrabarty, S., Agron, E., Chan, C.-C., Klein, M. L., et al. (2011) · Journal of Translational Medicine · doi:10.1186/1479-5876-9-111 · Cited by 164
Human anaphylatoxin (C3a) from the third component of complement. Primary structure.
Hugli, T. (1975) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)40758-8 · Cited by 164
β‐arrestins and heterotrimeric G‐proteins: collaborators and competitors in signal transduction
DeFea, K. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707508 · Cited by 162
Phylogenetic aspects of the complement system
Zarkadis, I. K., Mastellos, D., & Lambris, J. D. (2001) · Developmental & Comparative Immunology · doi:10.1016/s0145-305x(01)00034-9 · Cited by 161
Essential role for the second extracellular loop in C5a receptor activation
Klco, J. M., Wiegand, C. B., Narzinski, K., & Baranski, T. (2005) · Nature Structural & Molecular Biology · doi:10.1038/nsmb913 · Cited by 158
The Complement Factor C5a Contributes to Pathology in a Rat Model of Amyotrophic Lateral Sclerosis
Woodruff, T. M., Costantini, K. J., Crane, J. W., Atkin, J. D., Monk, P. N., Taylor, S. M., & Noakes, P. G. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.12.8727 · Cited by 156
Self-citationTherapeutic activity of C5a receptor antagonists in a rat model of neurodegeneration
Woodruff, T. M., Crane, J. W., Proctor, L. M., Buller, K. M., Shek, A., Vos, K. J. D., Pollitt, S., Williams, H. M., Shiels, I. A., Monk, P. N., et al. (2006) · The FASEB Journal · doi:10.1096/fj.05-5814com · Cited by 154
Self-citationThe Role of Anaphylatoxins C3a and C5a in Regulating Innate and Adaptive Immune Responses
Peng, Q., Li, K., Sacks, S. H., & Zhou, W. (2009) · Inflammation & Allergy - Drug Targets · doi:10.2174/187152809788681038 · Cited by 154
Lee, J. S., Frevert, C. W., Wurfel, M. M., Peiper, S. C., Wong, V. A., Ballman, K. K., RUZINSKI, J. T., Rhim, J. S., Martin, T. R., & Goodman, R. B. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.10.5244 · Cited by 153
Development of C5a receptor antagonists. Differential loss of functional responses.
Konteatis, Z. D., Siciliano, S. J., Riper, G. V., Molineaux, C. J., Pandya, S., Fischer, P. A., Rosen, H., Mumford, R. A., & Springer, M. S. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.153.9.4200 · Cited by 151
A common step for signal transduction in G protein-coupled receptors
Oliveira, L., Paiva, A. C. M., Sander, C., & Vriend, G. (1994) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(94)90137-6 · Cited by 151
C3a Mediates Epithelial-to-Mesenchymal Transition in Proteinuric Nephropathy
Tang, Z., Lu, B., Hatch, E., Sacks, S. H., & Sheerin, N. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008040434 · Cited by 147
Mechanisms of C5a and C3a Complement Fragment-Induced [Ca2+]iSignaling in Mouse Microglia
Möller, T., Nolte, C., Burger, R., Verkhratsky, A., & Kettenmann, H. (1997) · Journal of Neuroscience · doi:10.1523/jneurosci.17-02-00615.1997 · Cited by 144
Receptors for complement C5a. The importance of C5aR and the enigmatic role of C5L2
Lee, H., Whitfeld, P. L., & Mackay, C. R. (2008) · Immunology and Cell Biology · doi:10.1038/sj.icb.7100166 · Cited by 143
The human complement fragment receptor, C5L2, is a recycling decoy receptor
Scola, A.-M., Johswich, K. O., Morgan, B. P., Klos, A., & Monk, P. N. (2008) · Molecular Immunology · doi:10.1016/j.molimm.2008.11.001 · Cited by 140
Self-citationCloning and Characterization of a Novel Murine β Chemokine Receptor, D6
Nibbs, R. J. B., Wylie, S. M., Pragnell, I. B., & Graham, G. J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.19.12495 · Cited by 139
Wagner, J., & Hugli, T. E. (1984) · Analytical Biochemistry · doi:10.1016/0003-2697(84)90308-7 · Cited by 139
Lee, H. M., Wu, W., Wysoczynski, M., Liu, R., Zuba‐Surma, E. K., Kucia, M., Ratajczak, J., & Ratajczak, M. Z. (2009) · Leukemia · doi:10.1038/leu.2009.158 · Cited by 139
Complement anaphylatoxin C5a contributes to hemodialysis-associated thrombosis
Kourtzelis, I., Markiewski, M. M., Doumas, M. N., Rafail, S., Kambas, K., Mitroulis, I., Panagoutsos, S. A., Passadakis, P., Vargemezis, V., Magotti, P., et al. (2010) · Blood · doi:10.1182/blood-2010-01-264051 · Cited by 137
Banda, N. K., Hyatt, S., Antonioli, A. H., White, J. T., Glogowska, M. J., Takahashi, K., Merkel, T. J., Stahl, G. L., Mueller‐Ortiz, S. L., Wetsel, R. A., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1102310 · Cited by 137
The complement cascade as a mediator of tissue growth and regeneration
Rutkowski, M. J., Sughrue, M. E., Kane, A. J., Ahn, B. J., Fang, S., & Parsa, A. T. (2010) · Inflammation Research · doi:10.1007/s00011-010-0220-6 · Cited by 137
Early Elevations of the Complement Activation Fragment C3a and Adverse Pregnancy Outcomes
Lynch, A. M., Gibbs, R. S., Murphy, J. R., Giclas, P. C., Salmon, J. E., & Holers, V. M. (2010) · Obstetrics and Gynecology · doi:10.1097/aog.0b013e3181fc3afa · Cited by 137
Heller, T., Hennecke, M., Baumann, U., Gessner, J. E., zu Vilsendorf, A. M., Baensch, M., Boulay, F., Kola, A., Klos, A., Bautsch, W., et al. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.2.985 · Cited by 136
Self-citationComplement C3 and cleavage products in cardiometabolic risk
Onat, A., Can, G., Rezvani, R., & Cianflone, K. (2011) · Clinica Chimica Acta · doi:10.1016/j.cca.2011.03.005 · Cited by 135
Structure of and influence of a tick complement inhibitor on human complement component 5
Fredslund, F., Laursen, N. S., Roversi, P., Jenner, L. B., Oliveira, C. L. P., Pedersen, J. S., Nunn, M. A., Lea, S. M., DiScipio, R. G., Sottrup‐Jensen, L., et al. (2008) · Nature Immunology · doi:10.1038/ni.1625 · Cited by 134
Klco, J. M., Lassere, T. B., & Baranski, T. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305606200 · Cited by 133
Human C5a and C5a analogs as probes of the neutrophil C5a receptor
Chenoweth, D. E., & Hugli, T. E. (1980) · Molecular Immunology · doi:10.1016/0161-5890(80)90067-x · Cited by 132
Evidence for a functional role of the second C5a receptor C5L2
Gao, H., Neff, T. A., Guo, R., Speyer, C. L., Sarma, J. V., Tomlins, S. A., Man, Y., Riedemann, N. C., Hoesel, L. M., Younkin, E. M., et al. (2005) · The FASEB Journal · doi:10.1096/fj.04-3424fje · Cited by 132
Crystal Structure Analysis and Molecular Model of Human C3a Anaphylatoxin
Huber, R., Scholze, H., PÂQUES, E. P., & Deisenhofer, J. (1980) · Hoppe-Seyler´s Zeitschrift für physiologische Chemie · doi:10.1515/bchm2.1980.361.2.1389 · Cited by 132
Thurman, J. M., Lenderink, A. M., Royer, P. A., Coleman, K. E., Zhou, J., Lambris, J. D., Nemenoff, R. A., Quigg, R. J., & Holers, V. M. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.3.1819 · Cited by 131
Venkatesha, R. T., Thangam, E. R. R. B., Zaidi, A. K., & Ali, H. (2004) · Molecular Immunology · doi:10.1016/j.molimm.2004.09.009 · Cited by 131
Acylation stimulating protein (ASP), an adipocyte autocrine: new directions
Cianflone, K., Maslowska, M., & Sniderman, A. D. (1999) · Seminars in Cell and Developmental Biology · doi:10.1006/scdb.1998.0272 · Cited by 131
Walton, T. A., Sandoval, C. M., Fowler, C. A., Pardi, A., & Sousa, M. C. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809275106 · Cited by 128
Fischer, W. H., & Hugli, T. E. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.9.4279 · Cited by 128
Purification and Characterization of Acylation Stimulating Protein
Cianflone, K., Sniderman, A. D., Walsh, M. J., Vu, H., Gagnon, J., & Rodríguez, M. A. C. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31275-9 · Cited by 127
Li, K., Anderson, K. J., Peng, Q., Noble, A., Lu, B., Kelly, A. P., Wang, N., Sacks, S. H., & Zhou, W. (2008) · Blood · doi:10.1182/blood-2008-05-156646 · Cited by 127
C5a receptor‐deficient dendritic cells promote induction of Treg and Th17 cells
Weaver, D. J., Reis, E. S., Pandey, M. K., Köhl, G., Harris, N. L., Gerard, C. J., & Köhl, J. (2009) · European Journal of Immunology · doi:10.1002/eji.200939333 · Cited by 127
Murray, I. V. J., Havel, P. J., Sniderman, A. D., & Cianflone, K. (2000) · Endocrinology · doi:10.1210/endo.141.3.7364 · Cited by 125
Complement C5 Mediates Experimental Tubulointerstitial Fibrosis
Boor, P., Konieczny, A., Villa, L., Schult, A. L., Diaeresis]cher, E. B., Rong, S., Kunter, U., van Roeyen, C. R. C., Polakowski, T., Hawlisch, H., et al. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006121343 · Cited by 124
Mapping of the C5a receptor signal transduction network in human neutrophils.
Buhl, A. M., Avdi, N. J., Worthen, G. S., & Johnson, G. L. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.19.9190 · Cited by 123
Complement Activation Pathways: A Bridge between Innate and Adaptive Immune Responses in Asthma
Wills-Karp, M. A. (2007) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200704-046aw · Cited by 122
Skokowa, J., Ali, S. R., Felda, O., Kumar, V. V., Konrad, S., Shushakova, N., Schmidt, R. E., Piekorz, R. P., Nürnberg, B., Spicher, K., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.5.3041 · Cited by 119
Mollison, K. W., Mandecki, W., Zuiderweg, E. R. P., Fayer, L., Fey, T. A., Krause, R. A., Conway, R. G., Miller, L., Edalji, R. P., & Shallcross, M. A. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.1.292 · Cited by 119
Activated Human T Lymphocytes Express a Functional C3a Receptor
Werfel, T., Kirchhoff, K., Wittmann, M., Begemann, G., Kapp, A., Heidenreich, F., Götze, O., & Zwirner, J. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.11.6599 · Cited by 117
Model Structure for the Inflammatory Protein C5a
Greer, J. (1985) · Science · doi:10.1126/science.3992245 · Cited by 117
C5a alters blood‐brain barrier integrity in experimental lupus
Jacob, A., Hack, B. K., Chiang, E. T., et al. (2010) · The FASEB Journal · doi:10.1096/fj.09-138834 · Cited by 117
Horino, K., Nishiura, H., Ohsako, T., Shibuya, Y., Hiraoka, T., Kitamura, N., & Yamamoto, T. (1998) · PubMed · Cited by 117
Dendritic cell function in allostimulation is modulated by C5aR signaling
Peng, Q., Li, K., Wang, N., Li, Q., Asgari, E., Lu, B., Woodruff, T. M., Sacks, S. H., & Zhou, W. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0804186 · Cited by 116
Angiotensin II Receptor Endocytosis Involves Two Distinct Regions of the Cytoplasmic Tail
Thomas, W. G., Baker, K. M., Motel, T. J., & Thekkumkara, T. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.38.22153 · Cited by 115
DeMartino, J. A., Riper, G. V., Siciliano, S. J., Molineaux, C. J., Konteatis, Z. D., Rosen, H., & Springer, M. S. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36643-7 · Cited by 114
Complement component C5a activates ICAM-1 expression on human choroidal endothelial cells
Skeie, J. M., Fingert, J. H., Russell, S. R., Stone, E. M., & Mullins, R. F. (2010) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.10-5322 · Cited by 114
Complement Factors C3a, C4a, and C5a in Chronic Obstructive Pulmonary Disease and Asthma
Marc, M. M., Korošec, P., Košnik, M., Kern, I., Fležar, M., Šuškovič, S., & Šorli, J. (2004) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2003-0394oc · Cited by 114
Complement 5a Receptor Inhibition Improves Renal Allograft Survival
Gueler, F., Rong, S., Gwinner, W., Mengel, M., Bröcker, V., Schön, S., Greten, T. F., Hawlisch, H., Polakowski, T., Schnatbaum, K., et al. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007111267 · Cited by 114
Locati, M., de la Torre, Y. M., Galliera, E., Bonecchi, R., Haribabu, B., Vago, G. G., Vecchi, A., & Mantovani, A. (2005) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2005.05.003 · Cited by 111
Innate immunity as orchestrator of stem cell mobilization
Ratajczak, M. Z., Kim, C. H., Wojakowski, W., Janowska‐Wieczorek, A., Kucia, M., & Ratajczak, J. (2010) · Leukemia · doi:10.1038/leu.2010.162 · Cited by 110
Norgauer, J., Dobos, G., Kownatzki, E., Dahinden, C. A., Bürger, R., KUPPER, R., & Gierschik, P. (1993) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1993.tb18245.x · Cited by 109
Recent developments in low molecular weight complement inhibitors
Qu, H., Ricklin, D., & Lambris, J. D. (2009) · Molecular Immunology · doi:10.1016/j.molimm.2009.08.032 · Cited by 109
Lee, I., Chen, C., Sheu, J., Lee, M., Huang, G., Chen, D., Yu, C.-Y., Wen, C., Lu, F., & Chow, L. (2006) · PROTEOMICS · doi:10.1002/pmic.200500488 · Cited by 108
Kashem, S. W., Subramanian, H., Collington, S. J., Magotti, P., Lambris, J. D., & Ali, H. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.06.027 · Cited by 108
Persson, L. M., Borén, J., Robertson, A.-K. L., Wallenius, V., Hansson, G. K., & Pekna, M. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000127302.24266.40 · Cited by 106
Chemokines on the move: control by the chemokine “interceptors” Duffy blood group antigen and D6
Nibbs, R. J. B., Graham, G. J., & Rot, A. (2003) · Seminars in Immunology · doi:10.1016/j.smim.2003.08.006 · Cited by 105
Demonstration of a specific receptor for human C5a anaphylatoxin on murine macrophages.
Chenoweth, D. E., Goodman, M. G., & Weigle, W. O. (1982) · The Journal of Experimental Medicine · doi:10.1084/jem.156.1.68 · Cited by 105
Liu, J., Lin, F., Strainic, M. G., An, F., Miller, R. H., Altuntas, C. Z., Heeger, P. S., Tuohy, V. K., & Medof, M. E. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.9.5882 · Cited by 105
C5 deficiency and C5a or C5aR blockade protects against cerebral malaria
Patel, S. N., Berghout, J., Lovegrove, F. E., Ayi, K., Conroy, A. L., Serghides, L., Min‐Oo, G., Gowda, D. C., Sarma, J. V., Rittirsch, D., et al. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20072248 · Cited by 105
Receptors for the anaphylatoxins C3a and C5a are expressed in human atherosclerotic coronary plaques
Oksjoki, R. K., Laine, P., Helske, S., Vehmaan-Kreula, P., Mäyränpää, M. I., Gasque, P., Kovanen, P. T., & Pentikäinen, M. O. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.12.016 · Cited by 104
Strachan, A. J., Woodruff, T. M., Haaima, G., Fairlie, D. P., & Taylor, S. M. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.12.6560 · Cited by 102
Wilden, U., Wüst, E., Weyand, I., & Kühn, H. (1986) · FEBS Letters · doi:10.1016/0014-5793(86)81507-1 · Cited by 102
Husmann, L. K., Yung, D. L., Hollingshead, S. K., & Scott, J. R. (1997) · Infection and Immunity · doi:10.1128/iai.65.4.1422-1430.1997 · Cited by 102
Identification of four novel human G protein-coupled receptors expressed in the brain
Lee, D.-K., George, S. R., Cheng, R., Nguyen, T., Liu, Y., Brown, M., Lynch, K. R., & O’Dowd, B. F. (2001) · Molecular Brain Research · doi:10.1016/s0169-328x(00)00242-4 · Cited by 101
Generation of Anaphylatoxins by Human β-Tryptase from C3, C4, and C5
Fukuoka, Y., Xia, H.-Z., Sánchez‐Muñoz, L., Dellinger, A. L., Escribano, L., & Schwartz, L. B. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.9.6307 · Cited by 101
Campbell, W. D., Okada, N., & Okada, H. (2001) · Immunological Reviews · doi:10.1034/j.1600-065x.2001.1800114.x · Cited by 100
Zuiderweg, E. R. P., Nettesheim, D. G., Mollison, K. W., & Carter, G. W. (1989) · Biochemistry · doi:10.1021/bi00427a025 · Cited by 100
Gonzalez, J., Dong, Z., Romero, R. J., & Girardi, G. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026877 · Cited by 100
Identification of a Potent and Orally Active Non-peptide C5a Receptor Antagonist
Sumichika, H., Sakata, K., Sato, N., Takeshita, S., Ishibuchi, S., Nakamura, M., Kamahori, T., Ehara, S., Itoh, K., Ohtsuka, T., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m209672200 · Cited by 99
Lagane, B., Ballet, S., Planchenault, T., Balabanian, K., Poul, E. L., Blanpain, C., Percherancier, Y., Staropoli, I., Vassart, G., Oppermann, M., et al. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.009779 · Cited by 99
Xia, Z., Sniderman, A. D., & Cianflone, K. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m207281200 · Cited by 98
Evaluation of C3a receptor expression on human leucocytes by the use of novel monoclonal antibodies
Zwirner, Götze, Begemann, Kapp, A., Kirchhoff, & Werfel (1999) · Immunology · doi:10.1046/j.1365-2567.1999.00764.x · Cited by 97
Increased Serum Levels of Complement C3a Anaphylatoxin Indicate the Presence of Colorectal Tumors
Habermann, J. K., Roblick, U. J., Luke, B. T., Prieto, D. A., Finlay, W. J. J., Podust, V. N., Roman, J. M., Oevermann, E., Schiedeck, T. H. K., Homann, N., et al. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.07.011 · Cited by 97
A Critical Role for C5L2 in the Pathogenesis of Experimental Allergic Asthma
Zhang, X., Schmudde, I., Laumonnier, Y., Pandey, M. K., Clark, J. R., König, P., Gerard, N. P., Gerard, C. J., Wills-Karp, M. A., & Köhl, J. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000892 · Cited by 97
Circulating complement proteins in patients with sepsis or systemic inflammatory response syndrome
Stöve, S., Welte, T., Wagner, T., Kola, A., Klos, A., Bautsch, W., & Köhl, J. (1996) · Clinical and Diagnostic Laboratory Immunology · doi:10.1128/cdli.3.2.175-183.1996 · Cited by 96
Self-citationCianflone, K., Maslowska, M., & Sniderman, A. D. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114497 · Cited by 95
Characterization of C3a and C5a Receptors in Rat Cerebellar Granule Neurons during Maturation
Bénard, M., Gonzalez, B. J., Schouft, M., Falluel‐Morel, A., Vaudry, D., Chan, P., Vaudry, H., & Fontaine, M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404124200 · Cited by 94
The C3a receptor antagonist SB 290157 has agonist activity
Mathieu, M., Sawyer, N., Greig, G. M., Hamel, M., Kargman, S., Ducharme, Y., Lau, C. K., Friesen, R. W., O’Neill, G. P., Gervais, F. G., et al. (2005) · Immunology Letters · doi:10.1016/j.imlet.2005.03.003 · Cited by 94
Chemoattractant Receptors Activate Distinct Pathways for Chemotaxis and Secretion
Haribabu, B., Zhelev, D. V., Pridgen, B. C., Richardson, R. M., Ali, H., & D, R. S. M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.52.37087 · Cited by 93
Haas, P., de Haas, C. J. C., Kleibeuker, W., Poppelier, M. J. J. G., van Kessel, K. P. M., Kruijtzer, J. A. W., Liskamp, R. M. J., & van Strijp, J. A. G. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.9.5704 · Cited by 93
Complement C5a inhibition reduces atherosclerosis in ApoE –/– mice
Manthey, H. D., Thomas, A. C., Shiels, I. A., Zernecke, A., Woodruff, T. M., Rolfe, B. E., & Taylor, S. M. (2011) · The FASEB Journal · doi:10.1096/fj.10-174284 · Cited by 91
Jusko, M., Potempa, J., Karim, A., Książęk, M., Riesbeck, K., Garred, P., Eick, S., & Blom, A. M. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1101240 · Cited by 91
Variations in the C3, C3a receptor, and C5 genes affect susceptibility to bronchial asthma
Hasegawa, K., Tamari, M., Shao, C., Shimizu, M., Takahashi, N., Mao, X., Yamasaki, A., Kamada, F., Doi, S., Fujiwara, H., et al. (2004) · Human Genetics · doi:10.1007/s00439-004-1157-z · Cited by 91
Isolation and characterization of the subunits of human plasma carboxypeptidase N (kininase i).
Levin, Y., Skidgel, R. A., & Erdös, E. G. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.15.4618 · Cited by 89
Koistinen, H. A., Vidal, H., Karonen, S.-L., Dusserre, E., Vallier, P., Koivisto, V. A., & Ebeling, P. (2001) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.21.6.1034 · Cited by 89
Randolph‐Habecker, J., Rahill, B. M., Torok‐Storb, B., Vieira, J., Kolattukudy, P. E., Rovin, B. H., & Sedmak, D. D. (2002) · Cytokine · doi:10.1006/cyto.2002.0874 · Cited by 88
Ager, R. R., Fonseca, M. I., Chu, S., Sanderson, S. D., Taylor, S. M., Woodruff, T. M., & Tenner, A. J. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06595.x · Cited by 87
Heimbach, L., Li, Z., Berkowitz, P., Zhao, M., Li, N., Rubenstein, D. S., Diaz, L. A., & Liu, Z. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.221036 · Cited by 87
Garrett, M. C., Otten, M. L., Starke, R. M., Komotar, R. J., Magotti, P., Lambris, J. D., Rynkowski, M. A., & Connolly, E. S. (2009) · Brain Research · doi:10.1016/j.brainres.2009.04.047 · Cited by 86
Nociceptive sensitization by complement C5a and C3a in mouse
Jang, J. H., Clark, J. D., Li, X., Yorek, M. S., Usachev, Y. M., & Brennan, T. J. (2009) · Pain · doi:10.1016/j.pain.2009.11.021 · Cited by 86
Farzan, M., Schnitzler, C. E., Vasilieva, N. Y., Leung, D. G., Kuhn, J. H., Gerard, C. J., Gerard, N. P., & Choe, H. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.9.1059 · Cited by 85
Ducruet, A. F., Hassid, B. G., Mack, W. J., Sosunov, S. A., Otten, M. L., Fusco, D. J., Hickman, Z. L., Kim, G. H., Komotar, R. J., Mocco, J., et al. (2008) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600608 · Cited by 84
Ottonello, L. C., Corcione, A., Tortolina, G., Airoldi, I., Albesiano, E., Favre, A., D’Agostino, R., Malavasi, F., Pistoia, V., & Dallegri, F. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.11.6510 · Cited by 83
Klos, A., Bank, S., Gietz, C., Bautsch, W., Köhl, J., Burg, M., & Kretzschmar, T. (1992) · Biochemistry · doi:10.1021/bi00161a003 · Cited by 83
Self-citation
Cited by
Complement System Part II: Role in Immunity
Merle, N. S., Noe, R., Halbwachs-Mecarelli, L., Fremeaux-Bacchi, V., & Roumenina, L. T. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00257 · Cited by 1,051
Neutrophil chemoattractant receptors in health and disease: Double-edged swords
Metzemaekers, M., Gouwy, M., & Proost, P. (2020) · Cellular & Molecular Immunology · doi:10.1038/s41423-020-0412-0 · Cited by 570
Complement component C3 – The “Swiss Army Knife” of innate immunity and host defense
Ricklin, D., Reis, E. S., Mastellos, D. C., Gros, P., & Lambris, J. D. (2016) · Immunological Reviews · doi:10.1111/imr.12500 · Cited by 484
New insights into the immune functions of complement
Reis, E. S., Mastellos, D. C., Hajishengallis, G., & Lambris, J. D. (2019) · Nature Reviews Immunology · doi:10.1038/s41577-019-0168-x · Cited by 470
Complement activation, regulation, and molecular basis for complement‐related diseases
Bajic, G., Degn, S. E., Thiel, S., & Andersen, G. R. (2015) · The EMBO Journal · doi:10.15252/embj.201591881 · Cited by 374
Metadata
- Authors
- Klos, A., Wende, E., Wareham, K. J., & Monk, P. N.
- Venue
- Pharmacological Reviews
- Publisher
- Elsevier BV
- Published
- 2013-01
- Volume
- 65
- Issue
- 1
- Pages
- 500-543
- ISSN
- 0031-6997 (ISSN-L)
- OpenAlex
- W2126878361
- Cited by
- 264
- References
- 424
- FWCI
- 13.37
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.